
News|Articles|October 21, 2023
2023 Fall Clinical Recap: Day 2
Author(s)Kaitlyn Bader, Senior Editor
Catch up on coverage from the second day of the 2023 Fall Clinical Dermatology Conference.
Advertisement
Shawn Kwatra, MD: Managing Prurigo Nodularis With Biologics
Kwatra reviewed skin lesions in PN and important treatment considerations for patients at Fall Clinical.
Utilizing Biologics in the Management of Moderate to Severe Atopic Dermatitis
April Armstrong, MD, MPH, and Peter Lio, MD, explained the science behind how AD impacts quality of life and biologics on the market to enhance treatment plans.
Camp Wonder: Supporting Children With Life-Threatening Skin Diseases
Francesca Tenconi, president and CEO of Children’s Skin Disease Foundation and Camp Wonder, presented at Fall Clinical 2023 about the challenges of chronic skin conditions in children.
Additional Inflammatory Disease Summit Content
Reviewing IDS 2023 and Psoriasis Clinical Cases With Tristan Hasbargen, PA-C
Patient Perspective: Solutions for Relief After Years of Pain and Itch
Breaking Down JAKs and TYKs
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5

















